📣 VC round data is live. Check it out!
- Public Comps
- Dr Agarwals
Dr Agarwals Valuation Multiples
Discover revenue and EBITDA valuation multiples for Dr Agarwals and similar public comparables like Agilon Health, OdontoPrev, Burjeel Holdings, Siloam Hospitals and more.
Dr Agarwals Overview
About Dr Agarwals
Dr Agarwal’s Health Care Ltd is engaged in eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lenses and accessories, and eye care related pharmaceutical products. It offer services such as Surgeries, Cataract surgeries, Refractive surgeries, Other surgeries, and Consultations, diagnoses and non-surgical treatments, Its products services include Sale of opticals and Sale of eye care-related pharmaceutical products. The company is engaged in single segment that is eye care and related services provided from its hospitals which are located in India and Africa. It generates maximum revenue from India.
Founded
2010
HQ

Employees
3.4K
Website
Sectors
Financials (LTM)
EV
$2B
Valuation Multiples
Start free trialDr Agarwals Financials
Dr Agarwals reported last 12-month revenue of $224M and EBITDA of $61M.
In the same LTM period, Dr Agarwals generated $175M in gross profit, $61M in EBITDA, and $15M in net income.
Revenue (LTM)
Dr Agarwals P&L
In the most recent fiscal year, Dr Agarwals reported revenue of $219M and EBITDA of $65M.
Dr Agarwals is profitable as of last fiscal year, with gross margin of 64%, EBITDA margin of 30%, and net margin of 6%.
Financial data powered by Morningstar, Inc.
Dr Agarwals Stock Performance
Dr Agarwals has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Dr Agarwals' stock price is $5.07.
Dr Agarwals share price decreased by 0.6% in the last 30 days, and increased by 15.6% in the last year.
Dr Agarwals has an EPS (earnings per share) of $0.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | -0.6% | -0.6% | 16.4% | 15.6% | $0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDr Agarwals Valuation Multiples
Dr Agarwals trades at 7.5x EV/Revenue multiple, and 27.5x EV/EBITDA.
EV / Revenue (LTM)
Dr Agarwals Financial Valuation Multiples
As of June 2, 2026, Dr Agarwals has market cap of $2B and EV of $2B.
Dr Agarwals has a P/E ratio of 109.9x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Dr Agarwals Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Dr Agarwals Margins & Growth Rates
Dr Agarwals grew revenue by 21% and EBITDA by 12% in the last fiscal year.
In the most recent fiscal year, Dr Agarwals reported gross margin of 64%, EBITDA margin of 30%, and net margin of 6%.
Dr Agarwals Margins
Dr Agarwals Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Dr Agarwals Operational KPIs
Dr Agarwals' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Dr Agarwals' Rule of 40 is 49% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Dr Agarwals' Rule of X is 81% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Dr Agarwals Competitors
Dr Agarwals competitors include Agilon Health, OdontoPrev, Burjeel Holdings, Siloam Hospitals, Surgery Partners, Ramsay Santé, Almoosa Health, Pediatrix, Draegerwerk and Aevis Victoria.
Most Dr Agarwals public comparables operate across Hospitals & Clinics.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.2x | 0.2x | (4.5x) | (8.3x) | |||
| - | 3.3x | - | 10.4x | |||
| 1.5x | 1.5x | 7.7x | 7.8x | |||
| 2.4x | 2.4x | 9.9x | 9.6x | |||
| 1.7x | 1.7x | 9.9x | 10.5x | |||
| 1.0x | - | 8.5x | - | |||
| 4.4x | 4.2x | 17.4x | - | |||
| 1.1x | 1.1x | 7.5x | 7.4x | |||
This data is available for Pro users. Sign up to see all Dr Agarwals competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Dr Agarwals
| When was Dr Agarwals founded? | Dr Agarwals was founded in 2010. |
| Where is Dr Agarwals headquartered? | Dr Agarwals is headquartered in India. |
| How many employees does Dr Agarwals have? | As of today, Dr Agarwals has over 3K employees. |
| Who is the CEO of Dr Agarwals? | Dr Agarwals' CEO is Adil Agarwal. |
| Is Dr Agarwals publicly listed? | Yes, Dr Agarwals is a public company listed on National Stock Exchange of India. |
| What is the stock symbol of Dr Agarwals? | Dr Agarwals trades under AGARWALEYE ticker. |
| When did Dr Agarwals go public? | Dr Agarwals went public in 2025. |
| Who are competitors of Dr Agarwals? | Dr Agarwals main competitors include Agilon Health, OdontoPrev, Burjeel Holdings, Siloam Hospitals, Surgery Partners, Ramsay Santé, Almoosa Health, Pediatrix, Draegerwerk, Aevis Victoria. |
| What is the current market cap of Dr Agarwals? | Dr Agarwals' current market cap is $2B. |
| What is the current revenue of Dr Agarwals? | Dr Agarwals' last 12 months revenue is $224M. |
| What is the current revenue growth of Dr Agarwals? | Dr Agarwals revenue growth (NTM/LTM) is 23%. |
| What is the current EV/Revenue multiple of Dr Agarwals? | Current revenue multiple of Dr Agarwals is 7.5x. |
| What is the current EBITDA of Dr Agarwals? | Dr Agarwals' last 12 months EBITDA is $61M. |
| What is Dr Agarwals' EBITDA margin? | Dr Agarwals' last 12 months EBITDA margin is 27%. |
| What is the current EV/EBITDA multiple of Dr Agarwals? | Current EBITDA multiple of Dr Agarwals is 27.5x. |
| What is the current FCF of Dr Agarwals? | Dr Agarwals' last 12 months FCF is ($6M). |
| What is Dr Agarwals' FCF margin? | Dr Agarwals' last 12 months FCF margin is (2%). |
| What is the current EV/FCF multiple of Dr Agarwals? | Current FCF multiple of Dr Agarwals is (301.7x). |
| How many companies Dr Agarwals has acquired to date? | Dr Agarwals hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Dr Agarwals has invested to date? | Dr Agarwals hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Dr Agarwals
Lists including Dr Agarwals
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.